Product Liability

Roundup Weedkiller (Glyphosate) Non-Hodgkin's Lymphoma Mass Tort – Bayer AG Ongoing Litigation

Roundup Weedkiller (Glyphosate) Non-Hodgkin's Lymphoma Mass Tort – Bayer AG Ongoing Litigation — Product Liability class action lawsuit

Case Overview

The Roundup glyphosate litigation is one of the largest and most consequential mass torts in American legal history. Since the International Agency for Research on Cancer (IARC) classified glyphosate — the active ingredient in Roundup — as 'probably carcinogenic to humans' in 2015, hundreds of thousands of plaintiffs have alleged that long-term Roundup exposure caused them to develop non-Hodgkin's lymphoma (NHL). When Bayer AG acquired Monsanto in 2018 for $63 billion, it inherited enormous legal liability: within two years, juries in California had returned verdicts of $289 million, $80 million, and $2 billion against Monsanto. In 2020, Bayer announced a landmark $10.9 billion settlement resolving approximately 125,000 cases, one of the largest product liability settlements in history.

Despite that settlement, new Roundup lawsuits continue to be filed at a rapid pace through 2025, with an estimated 60,000+ cases still active. Bayer has set aside additional billions in reserves and continues to fight certain cases at trial, recording mixed results. In 2024 and 2025, courts have issued conflicting rulings on federal preemption — specifically, whether EPA's determination that glyphosate is 'not likely carcinogenic' shields Bayer from state-law failure-to-warn claims. The U.S. Supreme Court declined to hear Bayer's preemption appeal in 2024, keeping the litigation alive and ensuring that Roundup cases will remain a defining mass tort well into the latter half of this decade.

Who May Qualify

Individuals who used Roundup or other glyphosate-containing herbicide products regularly (typically for one year or more) and were subsequently diagnosed with non-Hodgkin's lymphoma or a related blood cancer such as diffuse large B-cell lymphoma, follicular lymphoma, or chronic lymphocytic leukemia.

Frequently Asked Questions

Can I still file a Roundup lawsuit in 2025?

Yes — despite the prior $10.9 billion settlement, new Roundup cases are still being accepted. If you or a loved one developed non-Hodgkin's lymphoma after regular exposure to Roundup, you may still have a viable claim. Contact a mass tort attorney promptly, as statutes of limitations apply.

How much is a Roundup lawsuit worth?

Roundup settlements and verdicts have varied widely, from tens of thousands to millions of dollars depending on the severity of illness, length of exposure, and other factors. Bayer's 2020 settlement averaged roughly $160,000 per resolved claim, but individual trial verdicts have reached hundreds of millions.

Did the EPA say Roundup is safe?

The EPA has maintained that glyphosate is 'not likely to be carcinogenic to humans' at typical exposure levels, but the IARC (a WHO agency) classifies it as 'probably carcinogenic.' Courts have largely allowed state failure-to-warn claims to proceed despite the EPA's position, and the Supreme Court declined to grant Bayer preemption protection in 2024.

Related Cases

$110M Transamerica Life Insurance Class Action Settlement — Product Liability class action lawsuit

$110M Transamerica Life Insurance Class Action Settlement

Past
Product Liability
Transamerica Life Insurance agreed to a $110 million settlement to resolve claims regarding its failure to properly credit certain cash value increases on specific life insurance policies. The settlement applies to policyholders who owned or owned a universal life insurance policy that was active on January 1, 2016, and was identified by certain product names or attribute codes.
Clorox Contaminated Cleaner Class Action — Product Liability class action lawsuit

Clorox Contaminated Cleaner Class Action

Current
Product Liability
A class action lawsuit alleges that The Clorox Company sold scented cleaning products, such as Mistolin and Lestoil, that were potentially contaminated with the bacterium Pseudomonas aeruginosa. The plaintiffs claim the company failed to warn consumers about this danger, especially for those with weakened immune systems.
Hyundai Class Action Over Faulty Driver Monitoring System — Product Liability class action lawsuit

Hyundai Class Action Over Faulty Driver Monitoring System

Current
Product Liability
A class action lawsuit alleges that certain Hyundai vehicles are equipped with a defective direct driver monitoring system that compromises vehicle safety. The plaintiffs claim the system malfunctions, causing false alarms and sudden braking, and that the manufacturer was aware of the defect.